Results 191 to 200 of about 386,039 (382)

Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 [PDF]

, 1995
Zhen‐Qiang Pan, Joyce T. Reardon, Lei Li, Hernan Flores‐Rozas, Randy J. Legerski, Aziz Sancar, Jerard Hurwitz   +6 more
openalex   +1 more source

Cyclin-Dependent Kinase Inhibition in Prostate Cancer: Past, Present, and Future. [PDF]

Cancers (Basel)
Siskin M, Economides MP, Wise DR.
europepmc   +1 more source

The Yeast Carboxyl-Terminal Repeat Domain Kinase CTDK-I Is a Divergent Cyclin–Cyclin-Dependent Kinase Complex [PDF]

, 1995
David E. Sterner, Jae Moon Lee, S. E. Hardin, Arno L. Greenleaf   +3 more
openalex   +1 more source

Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high‐grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models

Cancer Communications, EarlyView.
Monika Raab, Balázs Győrffy, Samuel Peña‐Llopis, Daniela Fietz, Monika Kressin, Margareta Kolaric, Matthias Ebert, Khayal Gasimli, Sven Becker, Mourad Sanhaji, Klaus Strebhardt   +10 more
wiley   +1 more source

Continuing Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Advanced Breast Cancer: A Meta-Analysis. [PDF]

Cancers (Basel)
Pathak N, Kumar S, Gimenez DM, Di Iorio M, Savill J, Berner-Wygoda Y, Li M, Valiente CM, Cuthbert D, Gupta A, Arteaga DP, Batra A, Amir E, Mittal A.   +13 more
europepmc   +1 more source

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

Expert Opinion on Investigational Drugs, 2013
P. Bose, G. Simmons, S. Grant
semanticscholar   +1 more source

Somatic cell reprogramming for Parkinson's disease treatment

Ibrain, Volume 11, Issue 1, Page 59-73, Spring 2025.
The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley   +1 more source

Cyclin-dependent kinase 13 is indispensable for normal mouse heart development. [PDF]

J Anat
Waheed-Ullah Q, Wilsdon A, Abbad A, Rochette S, Bu'Lock F, Saed AA, Hitz MP, Brook JD, Loughna S.   +8 more
europepmc   +1 more source

G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts [PDF]

, 1998
Lisa Connell‐Crowley, Stephen J. Elledge, J. Wade Harper   +2 more
openalex   +1 more source

Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions

Ibrain, EarlyView.
Alzheimer's disease treatment is evolving rapidly, with emerging strategies targeting multiple disease pathways. This graphical abstract highlights the shift from traditional therapies to innovative approaches that hold promise for improving outcomes.
Tapas Kumar Mohapatra, Reena Rani Nayak, Ankit Ganeshpurkar, Prashant Tiwari, Dileep Kumar   +4 more
wiley   +1 more source